Table 4.
Total symptom scores in Xuan Bai Cheng Qi and control groups during 10 - day treatment
|
Total symptom scores |
Full analysis set |
Per - protocol analysis set |
||||
|---|---|---|---|---|---|---|
| |
XBCQ
a
|
Control
a
|
Treatment effect
b
|
XBCQ
a
|
Control
a
|
Treatment effect
b
|
| (n = 122) | (n = 122) | (95% CI; P -value) | (n = 122) | (n = 122) | (95% CI; P- value) | |
| 1 d |
19.70 (4.23) |
20.10 (4.28) |
-0.39 (-1.47, 0.68; .471) |
19.64 (4.24) |
20.09 (4.32) |
-0.45 (-1.56, 0.67; .433) |
| 3 d |
13.92 (4,46) |
16.48 (4.08) |
-2.57 (-3.64, -1.49; < .001) |
13.82 (4.50) |
16.42 (3.95) |
-2.60 (-3.70, -1.49; < .001) |
| 5 d |
10.64 (4.28) |
13.20 (4.18) |
-2.56 (-3.63, -1.49; < .001) |
10.59 (4.24) |
13.12 (4.10) |
-2.52 (-3.61, -1.44; < .001) |
| 7 d |
7.72 (4.34) |
9.64 (3.68) |
-1.92 (-2.93, -0.90; < .001) |
7.64 (4.38) |
9.54 (3.65) |
-1.90 (-2.95, -0.86; < .001) |
| 10 d |
5.21 (4.43) |
7.00 (3.72) |
-1.79 (-2.82, -0.76; 0.001) |
5.03 (4.29) |
6.92 (3.74) |
-1.89 (-2.93, -0.84; < .001) |
| Meanc | 11.44 (3.36) | 13.28 (3.09) | -1.84 (-2.66, -1.03; < .001) | 11.34 (3.40) | 13.22 (3.05) | -1.87 (-2.71, -1.03; < .001) |
Abbreviations: CI confidence interval, XBCQ Xuan Bai Cheng Qi.
Mauchly’s test of sphericity was applied: W = .506, P < .001.
aData presented as mean (SD).
bRepeated-measures analysis of variance (ANOVA) for estimate with 95% confidence interval for difference.
cMean = change from baseline.